The forefront of global change.

The forefront of global change

Before a global prohibition emerged in the twentieth century, cultures around the world had used cannabis medicinally for thousands of years. The case for modern medical usage is an increasingly compelling one.

The cannabis compound cannabidiol, or CBD, is compatible with receptors in the human endocannabinoid system, which governs many physiological and cognitive functions, including those involving pain, mood and memory. In December 2017, the World Health Organization concluded CBD should be removed from international controlled substance schedules, further validating the compound’s medicinal potential. Even before the WHO recommendation, a number of jurisdictions permitted its use to ease or treat a range of conditions – from depression to nausea.

As the retail marketplace for cannabis grows, so will the medical one.

Pain Killers
  • Medical use
  • 40% adult penetration
  • $50–200 monthly spend
  • Medical use
  • 25% adult penetration
  • $50–100 monthly spend
  • Recreational and medical use
  • 20% adult penetration
  • $50–500 monthly spend

Similar to other highly regulated markets, including agriculture and traditional pharmaceuticals, successful players in medical cannabis will require more than deep knowledge of their products – many of which don’t yet exist. They will also need the equity and active management to scale their operations, as well as the know-how to navigate complex regulatory and quality-control frameworks.

A better alternative

  • 86% of cannabis users with anxiety reduce their use of prescribed medication, with 40% replacing it entirely with cannabis
  • 95% of cannabis users with prescriptions reduce opiate use, with 26% stopping it altogether

Conditions CBD might benefit

Alzheimer’s disease
Inflammatory bowel syndrome and Crohn’s disease
Inflammatory diseases
Multiple sclerosis
Cardiovascular diseases
Diabetic complications
Parkinson’s disease
Huntington’s disease
Hypoxia-ischemia injury
Rheumatoid arthritis

While numerous studies have shown that CBD has numerous health benefits, the full extent is still unknown. Stigma surrounds cannabis even within the research community. But legal recreational use and education throughout North America and Europe will further normalize cannabis – prompting additional research interest and investment in therapeutic and anti-inflammatory applications.